{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:51:15Z","timestamp":1792608675804,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10787-020-00773-9","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T07:02:42Z","timestamp":1604732562000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":264,"title":["The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Apurva","family":"Hariharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-3848","authenticated-orcid":false,"given":"Abdul Rahman","family":"Hakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subathra","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mettu Srinivas","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.013","author":"RA Al-Lami","year":"2020","unstructured":"Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J (2020) Sex hormones and novel corona virus infectious disease (COVID-19). Mayo Clin Proc. https:\/\/doi.org\/10.1016\/j.mayocp.2020.05.013","journal-title":"Mayo Clin Proc"},{"key":"773_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30238-2","author":"M Apicella","year":"2020","unstructured":"Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/S2213-8587(20)30238-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"773_CR3","doi-asserted-by":"crossref","first-page":"109778","DOI":"10.1016\/j.mehy.2020.109778","volume":"140","author":"SF Assimakopoulos","year":"2020","unstructured":"Assimakopoulos SF, Marangos M (2020) N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome. Med Hypotheses 140:109778","journal-title":"Med Hypotheses"},{"issue":"5234","key":"773_CR4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of IkappaB synthesis. Science 270(5234):286\u2013290","journal-title":"Science"},{"issue":"1","key":"773_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S (2011) NF-\u03baB, inflammation and metabolic disease. Cell Metab 13(1):11","journal-title":"Cell Metab"},{"issue":"16","key":"773_CR6","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1042\/CS20200904","volume":"134","author":"DS Battagello","year":"2020","unstructured":"Battagello DS, Dragunas G, Klein MO, Ayub ALP, Velloso FJ, Correa RG (2020) Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission. Clin Sci (Lond) 134(16):2137\u20132160. https:\/\/doi.org\/10.1042\/CS20200904","journal-title":"Clin Sci (Lond)"},{"key":"773_CR7","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc046","author":"SR Bauer","year":"2020","unstructured":"Bauer SR, Kapoor A, Rath M, Thomas SA (2020) What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Cleve Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc046","journal-title":"Cleve Clin J Med"},{"key":"773_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC et al (2020) Remdesivir for the treatment of COVID-19\u2014preliminary report. NEJM. https:\/\/doi.org\/10.1056\/NEJMoa2007764","journal-title":"NEJM"},{"issue":"3","key":"773_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2020.03.013","volume":"87","author":"M Benicco","year":"2020","unstructured":"Benicco M, Damiani A, Infantino M, Manfredi M, Quartuccio L (2020) Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine 87(3):195\u2013197","journal-title":"Joint Bone Spine"},{"issue":"3","key":"773_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","volume":"68","author":"D Birra","year":"2020","unstructured":"Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P et al (2020) COVID 19: a clue from innate immunity. Immunol Res 68(3):161\u2013168","journal-title":"Immunol Res"},{"key":"773_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00933-3","author":"N Bleyzac","year":"2002","unstructured":"Bleyzac N, Goutelle S, Bourguignon L, Tod M (2002) Azithromycin for COVID-19: more than just an antimicrobial? Clin Drug Investig. https:\/\/doi.org\/10.1007\/s40261-020-00933-3","journal-title":"Clin Drug Investig"},{"issue":"2","key":"773_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","volume":"86","author":"AR Brasier","year":"2010","unstructured":"Brasier AR (2010) The nuclear factor-\u03baB\u2013interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86(2):211\u2013218","journal-title":"Cardiovasc Res"},{"issue":"18","key":"773_CR13","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1158\/0008-5472.can-13-3171","volume":"74","author":"Y Cao","year":"2014","unstructured":"Cao Y, Slaney CY, Bidwell BN, Parker BS, Johnstone CN, Rautela J, Anderson RL (2014) BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Can Res 74(18):5091\u20135102. https:\/\/doi.org\/10.1158\/0008-5472.can-13-3171","journal-title":"Can Res"},{"issue":"1","key":"773_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-0191-1","volume":"5","author":"M Catanzaro","year":"2020","unstructured":"Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C (2020) Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Therapy 5(1):1\u201310","journal-title":"Signal Transduct Target Therapy"},{"issue":"6","key":"773_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","volume":"27","author":"L Catrysse","year":"2017","unstructured":"Catrysse L, Loo GV (2017) Inflammation and the metabolic syndrome: the tissue specific functions of NF-kB. Trends Cell Biol 27(6):417\u2013429","journal-title":"Trends Cell Biol"},{"issue":"5","key":"773_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39(5):529\u2013539","journal-title":"Semin Immunopathol"},{"issue":"1","key":"773_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/09273940903359725","volume":"18","author":"PS Cheung","year":"2010","unstructured":"Cheung PS, Si EC, Hosseini K (2010) Anti-inflammatory activity of azithromycin as measured by its NF-kappaB. Inhib Activ Ocul Immunol Inflamm 18(1):32\u201337","journal-title":"Inhib Activ Ocul Immunol Inflamm"},{"key":"773_CR18","unstructured":"ClinicalTrials.gov. Nitric oxide inhalation therapy for COVID-19 infections in the ED\u2014full text view. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04338828. Accessed 11 Aug 2020"},{"key":"773_CR19","unstructured":"ClinicalTrials.gov. Efficacy of n-acetylcysteine (NAC) in preventing COVID-19 from progressing to severe disease. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04419025. Accessed 11 Aug 2020"},{"key":"773_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L (2020) SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 54:62\u201375. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"773_CR21","unstructured":"COVID-19 coronavirus pandemic update (2020). https:\/\/www.worldometers.info\/coronavirus\/? Accessed 11 Aug 2020"},{"issue":"5","key":"773_CR22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/HYPERTENSIONAHA.114.04047","volume":"64","author":"SD Crowley","year":"2014","unstructured":"Crowley SD (2014) Linking angiotensin II to nuclear factor-\u03ba light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs. Hypertension 64(5):933\u2013934","journal-title":"Hypertension"},{"issue":"1","key":"773_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.2.1.22","volume":"2","author":"F D\u2019Acquisto","year":"2002","unstructured":"D\u2019Acquisto F, May MJ, Ghosh S (2002) Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv 2(1):22\u201335","journal-title":"Mol Interv"},{"key":"773_CR24","unstructured":"Das KC (2020) c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation. J Biol Chem. https:\/\/www.jbc.org\/content\/early\/2000\/11\/03\/jbc.M006206200.full.pdf. Accessed 11 Aug 2020"},{"key":"773_CR25","unstructured":"SECURE-IBD database\u2014surveillance epidemiology of coronavirus (COVID-19) under research exclusion. https:\/\/covidibd.org\/current-data\/. Accessed 11 Aug 2020"},{"issue":"2","key":"773_CR26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","volume":"395","author":"CW Day","year":"2009","unstructured":"Day CW, Baric R, Cai SX, Frieman M, Kumaki Y, Morrey JD et al (2009) A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology 395(2):210\u2013222","journal-title":"Virology"},{"key":"773_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14:523\u2013534","journal-title":"Nat Rev Microbiol"},{"key":"773_CR28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","volume":"15","author":"ML DeDiego","year":"2014","unstructured":"DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guarde\u00f1o JM, Fernandez-Delgado R, Fett C et al (2014) Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 15:913\u2013924","journal-title":"J Virol"},{"issue":"5","key":"773_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","volume":"51","author":"L Delgado-Roche","year":"2020","unstructured":"Delgado-Roche L, Mesta F (2020) Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res 51(5):384\u2013387. https:\/\/doi.org\/10.1016\/j.arcmed.2020.04.019","journal-title":"Arch Med Res"},{"issue":"3","key":"773_CR30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","volume":"53","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Raoult D (2020) ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425\u2013435","journal-title":"J Microbiol Immunol Infect"},{"key":"773_CR31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","volume":"10","author":"MG Dorrington","year":"2019","unstructured":"Dorrington MG, Fraser IDC (2019) NF-\u03baB Signaling in macrophages: dynamics, crosstalk, and signal integration. Front Immunol 10:705","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"773_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","volume":"142","author":"SF Dosch","year":"2009","unstructured":"Dosch SF, Mahajan SD, Collins AR (2009) SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res 142(1\u20132):19\u201327","journal-title":"Virus Res"},{"key":"773_CR33","unstructured":"Dutta D, Priya G, Joshi A (2020) COVID-19 and metabolic syndrome\u2014an association too difficult to ignore. https:\/\/www.touchendocrinology.com\/insight\/novel-coronavirus-disease-2019-covid-19-and-metabolic-syndrome-an-association-too-difficult-to-ignore\/. Accessed 11 Aug 2020."},{"issue":"10234","key":"773_CR34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","volume":"395","author":"M Feldmann","year":"2020","unstructured":"Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M et al (2020) Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 395(10234):1407\u20131409","journal-title":"Lancet"},{"key":"773_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13144","author":"YM Gao","year":"2019","unstructured":"Gao YM, Xu G, Wang B, Liu BC (2019) Cytokine storm syndrome in coronavirus disease: a narrative review. J Intern Med. https:\/\/doi.org\/10.1111\/joim.13144","journal-title":"J Intern Med"},{"issue":"7","key":"773_CR36","doi-asserted-by":"crossref","first-page":"e6422","DOI":"10.1371\/journal.pone.0006422","volume":"4","author":"MA Garcia","year":"2009","unstructured":"Garcia MA, Gallego P, Campagna M, Gonzalez-Santamaria J, Martinez G, Marcos-Villar L et al (2009) Activation of NF-kB pathway by virus infection requires Rb expression. PLoS ONE 4(7):e6422","journal-title":"PLoS ONE"},{"key":"773_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2020.05.007","author":"JM Grimes","year":"2020","unstructured":"Grimes JM, Grimes KV (2020) p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.05.007","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"773_CR38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/cvr\/cvq274","volume":"89","author":"T Hamid","year":"2011","unstructured":"Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD (2011) Cardiomyocyte NF-\u03baB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 89(1):129\u2013138","journal-title":"Cardiovasc Res"},{"issue":"1","key":"773_CR39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0008-6363(99)00425-3","volume":"46","author":"Y Hattori","year":"2000","unstructured":"Hattori Y, Hattori S, Sato N, Kasai K (2000) High-glucose-induced nuclear factor \u03baB activation in vascular smooth muscle cells. Cardiovasc Res 46(1):188\u2013197","journal-title":"Cardiovasc Res"},{"issue":"5","key":"773_CR40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano T, Murakami M (2020) COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(5):731\u2013733","journal-title":"Immunity"},{"issue":"1","key":"773_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL et al (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98(1):209\u2013218","journal-title":"Kidney Int"},{"key":"773_CR42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00912-2020","author":"NE Ingraham","year":"2020","unstructured":"Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG et al (2020) Understanding the renin-angiotensin-aldosterone-SARS-CoV-axis: a comprehensive review. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00912-2020","journal-title":"Eur Respir J"},{"key":"773_CR43","doi-asserted-by":"crossref","first-page":"102801","DOI":"10.1016\/j.ebiom.2020.102801","volume":"56","author":"FL Jean-Marie Berthelot","year":"2020","unstructured":"Jean-Marie Berthelot FL (2020) COVID-19 as a STING disorder with delayed over-secretion of interferon-beta. EBioMedicine 56:102801","journal-title":"EBioMedicine"},{"issue":"2","key":"773_CR44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.kint.2020.05.025","volume":"98","author":"KD Jhaveri","year":"2020","unstructured":"Jhaveri KD, Meir LR, Chang BSF, Parikh R, Wanchoo R, Barilla-LaBarca ML et al (2020) Thrombotic microangiopathy in a patient with COVID-19. Kidney Int 98(2):509\u2013512","journal-title":"Kidney Int"},{"key":"773_CR45","first-page":"m1252","volume":"368","author":"AJ Karadesh","year":"2020","unstructured":"Karadesh AJ (2020) COVID-19: what treatments are being investigated? BMJ 368:m1252","journal-title":"BMJ"},{"issue":"9","key":"773_CR46","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","volume":"6","author":"K Knoops","year":"2008","unstructured":"Knoops K, Kikkert M, van den Worm SHE, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ et al (2008) SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6(9):e226","journal-title":"PLoS Biol"},{"issue":"1","key":"773_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-020-00572-w","volume":"12","author":"M Krause","year":"2020","unstructured":"Krause M, Gerchman F, Friedman R (2020) Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications? Diabetol Metab Syndr 12(1):1\u20139","journal-title":"Diabetol Metab Syndr"},{"key":"773_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1790643","author":"SK Kunutsor","year":"2020","unstructured":"Kunutsor SK, Laukkanen JA (2020) Renal complications in COVID-19: a systematic review and meta-analysis. J Ann Med. https:\/\/doi.org\/10.1080\/07853890.2020.1790643","journal-title":"J Ann Med"},{"issue":"6","key":"773_CR49","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"773_CR50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","volume":"582","author":"H Ledford","year":"2020","unstructured":"Ledford H (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature 582:469","journal-title":"Nature"},{"issue":"10","key":"773_CR51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10):725\u2013734","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"773_CR52","first-page":"2436","volume":"15","author":"N Liang","year":"2018","unstructured":"Liang N, Zhong Y, Zhou J, Liu B, Lu R, Guan Y et al (2018) Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-\u03baB signaling pathway in lupus nephritis mice. Exp Ther Med 15(3):2436","journal-title":"Exp Ther Med"},{"issue":"9","key":"773_CR53","first-page":"607","volume":"37","author":"QJ Liao","year":"2005","unstructured":"Liao QJ, Ye LB, Timani KA, Zeng YC, She YL, Ye L et al (2005) Activation of NF-kB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim Biophys 37(9):607\u2013612","journal-title":"Acta Biochim Biophys"},{"key":"773_CR54","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-kB signalling in inflammation. Signal Transduct Target Ther 2:17023","journal-title":"Signal Transduct Target Ther"},{"key":"773_CR55","doi-asserted-by":"publisher","DOI":"10.1017\/s1049023x20000837","author":"P Maleki Dana","year":"2020","unstructured":"Maleki Dana P, Sadoughi F, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B, Momen-Heravi M (2020) An insight into the sex differences in COVID-19 patients: what are the possible causes? Prehosp Disaster Med. https:\/\/doi.org\/10.1017\/s1049023x20000837","journal-title":"Prehosp Disaster Med"},{"issue":"8","key":"773_CR56","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1084\/jem.20150218","volume":"212","author":"EK Malle","year":"2015","unstructured":"Malle EK, Zammit NW, Walters SN, Koay YC, Wu J, Tan BM et al (2015) Nuclear factor kB-inducing kinase activation as a mechanism of pancreatic beta cell failure in obesity. J Exp Med 212(8):1239\u20131254","journal-title":"J Exp Med"},{"issue":"1","key":"773_CR57","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/nar\/24.12.2236","volume":"12","author":"JR Matthews","year":"1996","unstructured":"Matthews JR, Botting CH, Panico M, Morris HR, Hay RT (1996) Inhibition of NF-B DNA binding by nitric oxide. Nucleic Acids Res 12(1):2236\u20132242","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"773_CR58","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.4049\/jimmunol.168.12.6429","volume":"168","author":"TR Meusel","year":"2002","unstructured":"Meusel TR, Kehoe KE, Imani F (2002) Protein kinase R regulates double-stranded RNA induction of TNF-a but not IL-Ib mRNA in human epithelial cells. J Immunol 168(12):6429\u20136435","journal-title":"J Immunol"},{"issue":"2","key":"773_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-16-0183","volume":"61","author":"K Meyerovich","year":"2018","unstructured":"Meyerovich K, Ortis F, Cardozo AK (2018) The non-canonical NF-\u03baB pathway and its contribution to \u03b2-cell failure in diabetes. J Mol Endocrinol 61(2):1\u20136","journal-title":"J Mol Endocrinol"},{"key":"773_CR60","doi-asserted-by":"crossref","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921","journal-title":"Clin Neurol Neurosurg"},{"key":"773_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110111","author":"N Mozafari","year":"2020","unstructured":"Mozafari N, Azadi S, Mehdi-Alamdarlou S, Ashrafi H, Azadi A (2020) Inflammation: a bridge between diabetes and COVID-19, and possible management with sitagliptin. Med Hypotheses. https:\/\/doi.org\/10.1016\/j.mehy.2020.110111","journal-title":"Med Hypotheses"},{"key":"773_CR62","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.18632\/aging.103344","volume":"12","author":"AL Mueller","year":"2020","unstructured":"Mueller AL, McNamara MS, Sinclair DA (2020) Why does COVID-19 disproportionately affect older people? Aging 12:9959\u20139981. https:\/\/doi.org\/10.18632\/aging.103344","journal-title":"Aging"},{"key":"773_CR63","doi-asserted-by":"publisher","DOI":"10.15761\/HMO.1000210","author":"EU Nwose","year":"2020","unstructured":"Nwose EU, Bwititi PT (2020) Complementary antioxidant medicine in COVID-19 management and the place of haematology evaluation: brief critical and scoping review-based commentary. Hematol Med Oncol. https:\/\/doi.org\/10.15761\/HMO.1000210","journal-title":"Hematol Med Oncol"},{"issue":"4","key":"773_CR64","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1(4):a000034","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2\u20133","key":"773_CR65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","volume":"472","author":"S Oka","year":"2000","unstructured":"Oka S, Kamata H, Kamata K, Yagisawa H, Hirata H (2000) N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases. FEBS Lett 472(2\u20133):196\u2013202","journal-title":"FEBS Lett"},{"issue":"3","key":"773_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.HYP.0000256831.33459.ea","volume":"49","author":"JK Park","year":"2007","unstructured":"Park JK, Fischer R, Dechend R, Shagdarsuren E, Gapeljuk A, Wellner M, Meiners S, Gratze P, Al-Saadi N, Feldt S, Fiebeler A, Madwed JB, Schirdewan A, Haller H, Luft FC, Muller DN (2007) p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 49(3):481\u2013489. https:\/\/doi.org\/10.1161\/01.HYP.0000256831.33459.ea","journal-title":"Hypertension"},{"key":"773_CR67","doi-asserted-by":"crossref","first-page":"101844","DOI":"10.1016\/j.tmaid.2020.101844","volume":"37","author":"SK Patel","year":"2020","unstructured":"Patel SK, Saikumar G, Rana J, Dharma J, Yatoo MI, Tiwari R et al (2020) Dexamethasone: a boon for critically ill COVID-19 patients? Travel Med Infect Dis 37:101844","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"773_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni748","volume":"3","author":"S Saccani","year":"2002","unstructured":"Saccani S, Pantano S, Natoli G (2002) p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3(1):69\u201375. https:\/\/doi.org\/10.1038\/ni748","journal-title":"Nat Immunol"},{"issue":"2","key":"773_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.arr.2007.09.002","volume":"7","author":"A Salminen","year":"2008","unstructured":"Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2008) Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7(2):83\u2013105. https:\/\/doi.org\/10.1016\/j.arr.2007.09.002","journal-title":"Ageing Res Rev"},{"key":"773_CR70","doi-asserted-by":"publisher","unstructured":"Sanghai N, Tranmer GK Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms. Drug Discov Tod 16:S1359-6446(20)30371-8. doi: https:\/\/doi.org\/10.1016\/j.drudis.2020.09.013","DOI":"10.1016\/j.drudis.2020.09.013"},{"issue":"8","key":"773_CR71","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2010020218","volume":"21","author":"AB Sanz","year":"2010","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M et al (2010) NF-\u03baB in renal inflammation. J Am Soc Nephrol 21(8):1254\u20131262","journal-title":"J Am Soc Nephrol"},{"key":"773_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0312-7","author":"G Schett","year":"2020","unstructured":"Schett G, Sticherling M, Neurath MF (2020) COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0312-7","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"773_CR73","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/jac\/dkv085","volume":"70","author":"S Shalhoub","year":"2015","unstructured":"Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N et al (2015) IFN-\u03b12a or IFN-\u03b21a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother 70(7):2129\u20132132","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"773_CR74","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.dsx.2020.06.054","volume":"14","author":"AK Singh","year":"2020","unstructured":"Singh AK, Majumdar S, Singh R, Misra A (2020) Role of corticosteroid in the management of COVID-19: a systematic review and a clinician\u2019s perspective. Diabetes Metab Syndr 14(5):971\u2013978","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"773_CR75","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P, Tabak F, Atag\u00fcnd\u00fcz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39(7):2085\u20132094","journal-title":"Clin Rheumatol"},{"key":"773_CR76","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"S Sun","year":"2017","unstructured":"Sun S (2017) The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol 17:545\u2013558. https:\/\/doi.org\/10.1038\/nri.2017.52","journal-title":"Nat Rev Immunol"},{"key":"773_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02942-2","author":"P Sw\u00e4rd","year":"2020","unstructured":"Sw\u00e4rd P, Edsfeldt A, Reepalu A, Jehpsson L, Rosengren BE, Karlsson MK (2020) Age and sex differences in soluble ACE2 may give insights for COVID-19. Crit Care. https:\/\/doi.org\/10.1186\/s13054-020-02942-2","journal-title":"Crit Care"},{"key":"773_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","author":"Y Tang","year":"2020","unstructured":"Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C (2020) Cytokine Storm in COVID-19: the current evidence and treatment strategies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01708","journal-title":"Front Immunol"},{"key":"773_CR79","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"The RECOVERY Collaborative Group","year":"2020","unstructured":"The RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with COVID-19\u2014preliminary report. NEJM. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"NEJM"},{"issue":"1","key":"773_CR80","first-page":"15","volume":"14","author":"DL Urso","year":"2020","unstructured":"Urso DL (2020) Coronavirus disease 2019 (COVID-19): a brief report. Clin Manag Issues 14(1):15\u201319","journal-title":"Clin Manag Issues"},{"issue":"45","key":"773_CR81","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","volume":"18","author":"BRG Williams","year":"1999","unstructured":"Williams BRG (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18(45):6112\u20136120","journal-title":"Oncogene"},{"key":"773_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE et al (2020) Factors associated with COVID-19-related deaths using OpenSAFELY. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"issue":"2","key":"773_CR83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3892\/mmr.2014.2292","volume":"10","author":"X Wu","year":"2014","unstructured":"Wu X, Luo A, Zhou Y, Ren J (2014) N-acetylcysteine reduces oxidative stress, nuclear factor-\u03baB activity and cardiomyocyte apoptosis in heart failure. Mol Med Rep 10(2):615\u2013624","journal-title":"Mol Med Rep"},{"issue":"7798","key":"773_CR84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG et al (2020) Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome GenBank: MN908947.3. Nature 579(7798):265\u2013269","journal-title":"Nature"},{"issue":"1","key":"773_CR85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","volume":"24","author":"Z Wu","year":"2020","unstructured":"Wu Z, Hu R, Zhang C, Ren W, Yu A, Zhou X (2020) Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit Care 24(1):290","journal-title":"Crit Care"},{"issue":"38","key":"773_CR86","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.274.38.27307","volume":"274","author":"Y Yamamoto","year":"1999","unstructured":"Yamamoto Y, Yin M-J, Lin K-M, Gaynor RB (1999) Sulindac inhibits activation of the NF-\u03baB pathway. J Biol Chem 274(38):27307\u201327314","journal-title":"J Biol Chem"},{"key":"773_CR87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91\u201395","journal-title":"Int J Infect Dis"},{"issue":"27","key":"773_CR88","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1503\/cmaj.200645","volume":"192","author":"Z Ye","year":"2020","unstructured":"Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B et al (2020) Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ 192(27):E756\u2013E767","journal-title":"CMAJ"},{"issue":"1\u20132","key":"773_CR89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D (2017) 30 years of NF-\u03baB: a blossoming of relevance to human pathobiology. Cell 168(1\u20132):37\u201357","journal-title":"Cell"},{"key":"773_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02033","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li B, Ning B (2020) The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.02033","journal-title":"Front Immunol"},{"issue":"7798","key":"773_CR91","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270","journal-title":"Nature"},{"key":"773_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01479-w","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y (2020) From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. https:\/\/doi.org\/10.1186\/s12931-020-01479-w","journal-title":"Respir Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-020-00773-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:21:10Z","timestamp":1614165670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-020-00773-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00773-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}